TrialMedical oncology (Northwood, London, England)2014

Predictive biomarkers for the efficacy of cetuximab combined with cisplatin and capecitabine in advanced gastric or esophagogastric junction adenocarcinoma: a prospective multicenter phase 2 trial.

Xiaotian Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.